نتایج جستجو برای: ipah gene

تعداد نتایج: 1141692  

2017
Shun Yanai Megumi Wakayama Haruo Nakayama Minoru Shinozaki Hisayuki Tsukuma Naobumi Tochigi Tetsuo Nemoto Tsutomu Saji Kazutoshi Shibuya

BACKGROUND Idiopathic pulmonary arterial hypertension (IPAH) is a rare, fatal disease of unknown pathogenesis. Evidence from our recent study suggests that IPAH pathogenesis is related to upregulation of the Wnt/planar cell polarity (Wnt/PCP) pathway. We used microscopic observation and immunohistochemical techniques to identify expression patterns of cascading proteins-namely Wnt-11, dishevell...

2015
Mohammad Reza Masjedi Fanak Fahimi Babak Sharif-Kashani Majid Malek Mohammad Leila Saliminejad Fateme Monjazebi

BACKGROUND Idiopathic pulmonary arterial hypertension (IPAH) is a fatal disorder with a prevalence of 8.6 per million. We introduce a registry website for IPAH and PAH patients ( www.IPAH.ir) for access and efficient delivery of government-aided and subsidized antihypertensive medications. MATERIALS AND METHODS The IPAH registry was opened in November 2009. Information of IPAH and PAH patient...

2015
Susana Hoette Claudia Figueiredo Bruno Dias Jose Leonidas Alves-Jr Francisca Gavilanes Luis Felipe Prada Dany Jasinowodolinski Luciana Tamie Kato Morinaga Carlos Jardim Caio Julio Cesar Fernandes Rogério Souza

BACKGROUND Schistosomiasis associated pulmonary arterial hypertension (Sch-PAH) might represent the most prevalent form of PAH worldwide. In Sch-PAH, the presence of aneurismal dilation of the pulmonary artery has been described, although it is still a matter of debate whether on average the pulmonary artery is more enlarged in Sc-PAH than IPAH. METHODS We retrospectively evaluated patients w...

2011
Maria J Overbeek Anco Boonstra Alexandre E Voskuyl Madelon C Vonk Anton Vonk-Noordegraaf Maria PA van Berkel Wolter J Mooi Ben AC Dijkmans Laurens S Hondema Egbert F Smit Katrien Grünberg

Introduction: Systemic sclerosis (SSc) complicated by pulmonary arterial hypertension (PAH) carries a poor prognosis, despite pulmonary vascular dilating therapy. Platelet-derived growth factor receptor-b (PDGFR-b) and epidermal growth factor receptor (EGFR) are potential therapeutic targets for PAH because of their proliferative effects on vessel remodelling. To explore their role in SScPAH, w...

Journal: :Circulation research 2006
Krystyna Teichert-Kuliszewska Michael J B Kutryk Michael A Kuliszewski Golnaz Karoubi David W Courtman Liana Zucco John Granton Duncan J Stewart

Mutations in the bone morphogenetic protein (BMP) receptor-2 (BMPR2) have been found in patients with idiopathic pulmonary arterial hypertension (IPAH); however, the mechanistic link between loss of BMPR2 signaling and the development of pulmonary arterial hypertension is unclear. We hypothesized that, contrary to smooth muscle cells, this pathway promotes survival in pulmonary artery endotheli...

2015
Andrew J. Swift Dave Capener Charlotte Hammerton Steven M. Thomas Charlie Elliot Robin Condliffe Jim M. Wild David G. Kiely James West

PURPOSE Sex differences exist in both the prevalence and survival of patients with idiopathic pulmonary arterial hypertension (IPAH). Men are less frequently affected by the condition but have worse outcome as compared to females. We sought to characterise the sex related differences in right ventricular remodelling in age matched male and female patients with IPAH using cardiac magnetic resona...

Journal: :American journal of physiology. Lung cellular and molecular physiology 2010
Amy L Firth Weijuan Yao Carmelle V Remillard Aiko Ogawa Jason X-J Yuan

Oct-4 is a transcription factor considered to be one of the defining pluripotency markers in embryonic stem cells. Its expression has also been demonstrated in adult stem cells, tumorigenic cells, and, most recently and controversially, in somatic cells. Oct-4 pseudogenes also contribute to carcinogenesis. Oct-4 may be involved in the excessive proliferation of pulmonary arterial smooth muscle ...

Journal: :European Heart Journal 2022

Abstract Background One of the most challenging differential diagnoses in pulmonary hypertension clinical practice, is discrimination between idiopathic arterial (IPAH) and due to heart failure with preserved ejection fraction (PH-HFpEF). Aim We elaborate a score (considering patient history, demographics, echocardiographic characteristics) that can predict, noninvasively, PH-HFpEF vs IPAH diag...

Journal: :Circulation 2016
Steven Hsu Brian A Houston Emmanouil Tampakakis Anita C Bacher Parker S Rhodes Stephen C Mathai Rachel L Damico Todd M Kolb Laura K Hummers Ami A Shah Zsuzsanna McMahan Celia P Corona-Villalobos Stefan L Zimmerman Fredrick M Wigley Paul M Hassoun David A Kass Ryan J Tedford

BACKGROUND Right ventricular (RV) functional reserve affects functional capacity and prognosis in patients with pulmonary arterial hypertension (PAH). PAH associated with systemic sclerosis (SSc-PAH) has a substantially worse prognosis than idiopathic PAH (IPAH), even though many measures of resting RV function and pulmonary vascular load are similar. We therefore tested the hypothesis that RV ...

Journal: :Pediatric pulmonology 2011
G Schaellibaum A E Lammers A Faro A Moreno-Galdo D Parakininkas M G Schecter M Solomon D Boyer C Conrad T Frischer J Wong A Boehler C Benden

Many children with idiopathic pulmonary arterial hypertension (IPAH) experience disease progression despite advanced medical therapy. In these children, heart-lung or bilateral lung transplantation (BLTx) remain the only therapeutic options when other treatments fail. Data on functional outcome after BLTx in children with IPAH are limited. We report a multi-center experience of BLTx for pediatr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید